Alexion Pharma Nordics AB
556839-1022ActivePioneering transformative medicines for the global rare disease community.
Yleiskatsaus
- 10–19
- Työntekijät
- 50–100milj SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Marc Dunoyer
Chief Executive Officer
Scott Weintraub
SVP, United States Business
Shane Doyle
SVP, Head of Operations
Ana Crespo
Communications Director Spain/Portugal
+16 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Alexion, operating as AstraZeneca Rare Disease, is fundamentally dedicated to pioneering new possibilities for the global rare disease community. Their core mission revolves around transforming the lives of people affected by rare conditions through the development of transformative treatments and m...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Provisionshandel med annat specialsortiment
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556839102201
Päättäjät
20 yhteystietoa FunnelfeedrissäMarc Dunoyer
Chief Executive Officer
Scott Weintraub
SVP, United States Business
Shane Doyle
SVP, Head of Operations
Ana Crespo
Communications Director Spain/Portugal
Soraya Bekkali
SVP, EUCAN and International Business
Nick France
VP and Therapeutic Area Head for Neurology and Genomic Medicine
Banu Sankaran
Head of Diagnostics Strategy & Development
Chathuri Daluwatte
Head of AI Diagnostics team
Adrian Kielhorn
Senior Director of Global Health Economics and Outcomes Research (HEOR)
Fred Chereau
SVP, Strategy & Business Development
Seng Cheng
SVP, Head of Research and Product Development
Sarah Marshall
VP, Head of Human Resources
Ruth Diazaraque
VP, Research and Development
Sophia Zilber
Associate Director, Statistical Programming
Christophe Hotermans
SVP, Medical Affairs
Mary Kunjappu
R&D Leading Voice
Sean Christie
Chief Financial and Administration Officer
Erica Deacon
VP, Head of Information Technology
Gianluca Pirozzi
SVP, Head of Development, Regulatory and Safety
Nicola Heffron
SVP, Head of Global Marketing & Market Access
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäASTRAZENECA PLC
1–4 työntekijätGlobal science-led pharmaceutical business developing life-changing medicines.
Alnylam Sweden AB
5–9 työntekijätLeading RNAi therapeutics company developing gene-silencing medicines.
AstraZeneca AB
5,000–9,999 työntekijätGlobal biopharmaceutical company developing life-changing medicines across key areas.
Angelini Pharma Nordics AB
10–19 työntekijätInternational pharmaceutical company focused on brain health and consumer care.
ASTRAZENECA AS
102 työntekijätGlobal science-led pharmaceutical company delivering life-changing medicines across key areas.
Selaa lisää
Kysymyksiä yrityksestä Alexion Pharma Nordics AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo